Structure Therapeutics Inc.

Pharmaceutical company · South San Francisco, California, United States · Nasdaq: GPCR

Structure Therapeutics Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker GPCR. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Structure Therapeutics at a glance

Typepharmaceutical company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2019
Stock listingNasdaq: GPCR
SEC industryPharmaceutical Preparations
SEC CIK1888886

What does Structure Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $7 million sold (2022).

Frequently asked questions about Structure Therapeutics

Where is Structure Therapeutics headquartered?

Structure Therapeutics Inc. is headquartered in South San Francisco, California, United States.

What does Structure Therapeutics do?

Structure Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Structure Therapeutics a public company?

Yes. Structure Therapeutics Inc. trades on Nasdaq under the ticker GPCR.

When was Structure Therapeutics founded?

The earliest incorporation on record for Structure Therapeutics Inc. is in 2019, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences